Your browser doesn't support javascript.
loading
Hyperoside prevents doxorubicin-induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway.
Wei, Shanshan; Ma, Wanjun; Jiang, Chuanhao; Liu, Jiaqin; Liu, Jian; Zhang, Bikui; Li, Wenqun.
Afiliación
  • Wei S; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Ma W; Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China.
  • Jiang C; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
  • Liu J; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Liu J; Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China.
  • Zhang B; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li W; Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Phytother Res ; 37(9): 4196-4209, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37246409
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inflamasomas / Cardiotoxicidad Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inflamasomas / Cardiotoxicidad Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article